ApoCell: Phase I/II data

By WIR Staff | Nov 12, 2012 | 8:00 AM GMT

An open-label, Israeli Phase I/II trial in 13 patients showed that

Read the full 111 word article

How to gain access

Continue reading with a
two-week free trial.